FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2795688422> ?p ?o ?g. }

• W2795688422 endingPage "205" @default.
• W2795688422 startingPage "196" @default.
• W2795688422 abstract "Bioprosthetic heart valves (BHVs) originating from pigs are extensively used for heart valve replacement in clinics. However, recipient immune responses associated with chronic calcification lead to structural valve deterioration (SVD) of BHVs. Two well-characterized epitopes on porcine BHVs have been implicated in SVD, including galactose-α1,3-galactose (αGal) and N-glycolylneuraminic acid (Neu5Gc) whose synthesis are catalyzed by α(1,3) galactosyltransferase (encoded by the GGTA1 gene) and CMP-Neu5Ac hydroxylase (encoded by the CMAH gene), respectively. It has been reported that BHV from αGal-knockout pigs are associated with a significantly reduced immune response by human serum. Moreover, valves from αGal/Neu5Gc-deficient pigs could further reduce human IgM/IgG binding when compared to BHV from αGal-knockout pigs. Recently, another swine xenoantigen, Sd(a), produced by β-1,4-N-acetyl-galactosaminyl transferase 2 (β4GalNT2), has been identified. To explore whether tissue from GGTA1, CMAH, and β4GalNT2 triple gene-knockout (TKO) pigs would further minimize human antibody binding to porcine pericardium, TKO pigs were successfully produced by CRISPR/Cas9 mediated gene targeting. Our results showed that the expression of αGal, Neu5G and Sd(a) on TKO pigs was negative, and that human IgG/IgM binding to pericardium was minimal. Moreover, the analysis of collagen composition and physical characteristics of porcine pericardium from the TKO pigs indicated that elimination of the three xenoantigens had no significant impact on the physical proprieties of porcine pericardium. Our results demonstrated that TKO pigs would be an ideal source of BHVs.Surgical heart valve replacement is an established lifesaving treatment for diseased heart valve. Bioprosthetic heart valves (BHVs) made from glutaraldehyde-fixed porcine or bovine tissues are widely used in clinics but exhibit age-dependent structural valve degeneration (SVD) which is associated with the immune response against BHVs. Three major xenoantigens present on commercial BHVs, Galactosea α1,3 galactose (αGal), N-glycolylneuraminic acid (Neu5Gc) and glycan products of β-1,4-N-acetyl-galactosaminyl transferase 2 (β4GalNT2) are eliminated through CRISPR/Cas9 mediated gene targeting in the present study. The genetically modified porcine pericardium showed reduced immunogenicity but comparable collagen composition and physical characteristics of the pericardium from wild-type pigs. Our data suggested that BHVs from TKO pigs is a promising alternative for currently available BHVs from wild-type pigs." @default.
• W2795688422 created "2018-04-13" @default.
• W2795688422 creator A5003686337 @default.
• W2795688422 creator A5003757306 @default.
• W2795688422 creator A5007120608 @default.
• W2795688422 creator A5010103014 @default.
• W2795688422 creator A5010191880 @default.
• W2795688422 creator A5010738468 @default.
• W2795688422 creator A5011085153 @default.
• W2795688422 creator A5015253156 @default.
• W2795688422 creator A5015511921 @default.
• W2795688422 creator A5021952312 @default.
• W2795688422 creator A5030348054 @default.
• W2795688422 creator A5033990324 @default.
• W2795688422 creator A5034294282 @default.
• W2795688422 creator A5036587412 @default.
• W2795688422 creator A5037035682 @default.
• W2795688422 creator A5051452798 @default.
• W2795688422 creator A5052363873 @default.
• W2795688422 creator A5067694348 @default.
• W2795688422 creator A5068952473 @default.
• W2795688422 creator A5073212256 @default.
• W2795688422 creator A5085492854 @default.
• W2795688422 creator A5089446649 @default.
• W2795688422 date "2018-05-01" @default.
• W2795688422 modified "2023-10-11" @default.
• W2795688422 title "Reducing immunoreactivity of porcine bioprosthetic heart valves by genetically-deleting three major glycan antigens, GGTA1/β4GalNT2/CMAH" @default.
• W2795688422 cites W108660209 @default.
• W2795688422 cites W1526477243 @default.
• W2795688422 cites W1972229141 @default.
• W2795688422 cites W1980834102 @default.
• W2795688422 cites W1986094205 @default.
• W2795688422 cites W1989861340 @default.
• W2795688422 cites W1991991195 @default.
• W2795688422 cites W1997921705 @default.
• W2795688422 cites W2012502143 @default.
• W2795688422 cites W2021260610 @default.
• W2795688422 cites W2021415784 @default.
• W2795688422 cites W2030595401 @default.
• W2795688422 cites W2042248138 @default.
• W2795688422 cites W2043037164 @default.
• W2795688422 cites W2051546362 @default.
• W2795688422 cites W2057858257 @default.
• W2795688422 cites W2070502969 @default.
• W2795688422 cites W2072309186 @default.
• W2795688422 cites W2082268143 @default.
• W2795688422 cites W2084409932 @default.
• W2795688422 cites W2090303367 @default.
• W2795688422 cites W2091505613 @default.
• W2795688422 cites W2094379416 @default.
• W2795688422 cites W2096234854 @default.
• W2795688422 cites W2098252984 @default.
• W2795688422 cites W2112352595 @default.
• W2795688422 cites W2114721006 @default.
• W2795688422 cites W2116381107 @default.
• W2795688422 cites W2158722130 @default.
• W2795688422 cites W2163938277 @default.
• W2795688422 cites W2265756380 @default.
• W2795688422 cites W2280972418 @default.
• W2795688422 cites W2411444623 @default.
• W2795688422 cites W2507761367 @default.
• W2795688422 cites W2511079952 @default.
• W2795688422 cites W2575274634 @default.
• W2795688422 cites W2622060281 @default.
• W2795688422 cites W2725242335 @default.
• W2795688422 cites W4253332709 @default.
• W2795688422 cites W896293506 @default.
• W2795688422 doi "https://doi.org/10.1016/j.actbio.2018.03.055" @default.
• W2795688422 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29631050" @default.
• W2795688422 hasPublicationYear "2018" @default.
• W2795688422 type Work @default.
• W2795688422 sameAs 2795688422 @default.
• W2795688422 citedByCount "66" @default.
• W2795688422 countsByYear W27956884222018 @default.
• W2795688422 countsByYear W27956884222019 @default.
• W2795688422 countsByYear W27956884222020 @default.
• W2795688422 countsByYear W27956884222021 @default.
• W2795688422 countsByYear W27956884222022 @default.
• W2795688422 countsByYear W27956884222023 @default.
• W2795688422 crossrefType "journal-article" @default.
• W2795688422 hasAuthorship W2795688422A5003686337 @default.
• W2795688422 hasAuthorship W2795688422A5003757306 @default.
• W2795688422 hasAuthorship W2795688422A5007120608 @default.
• W2795688422 hasAuthorship W2795688422A5010103014 @default.
• W2795688422 hasAuthorship W2795688422A5010191880 @default.
• W2795688422 hasAuthorship W2795688422A5010738468 @default.
• W2795688422 hasAuthorship W2795688422A5011085153 @default.
• W2795688422 hasAuthorship W2795688422A5015253156 @default.
• W2795688422 hasAuthorship W2795688422A5015511921 @default.
• W2795688422 hasAuthorship W2795688422A5021952312 @default.
• W2795688422 hasAuthorship W2795688422A5030348054 @default.
• W2795688422 hasAuthorship W2795688422A5033990324 @default.
• W2795688422 hasAuthorship W2795688422A5034294282 @default.
• W2795688422 hasAuthorship W2795688422A5036587412 @default.
• W2795688422 hasAuthorship W2795688422A5037035682 @default.
• W2795688422 hasAuthorship W2795688422A5051452798 @default.
• W2795688422 hasAuthorship W2795688422A5052363873 @default.
• W2795688422 hasAuthorship W2795688422A5067694348 @default.

• next